GF Fund Management’s Vertex Pharmaceuticals VRTX Stock Holding History

GF Fund Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.1M	Sell	62,678 -1,913	-3%	-$848K	0.37%	50
2026 Q1	$28.8M	Sell	64,591 -820	-1%	-$382K	0.48%	42
2025 Q4	$29.7M	Buy	65,411 +2,620	+4%	+$1.13M	0.51%	45
2025 Q3	$24.6M	Buy	62,791 +474	+0.8%	+$198K	0.45%	51
2025 Q2	$27.7M	Buy	62,317 +1,505	+2%	+$694K	0.56%	42
2025 Q1	$29.5M	Buy	60,812 +1,634	+3%	+$761K	0.69%	32
2024 Q4	$23.8M	Buy	+59,178	New	+$27.4M	0.52%	40

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

GF Fund Management's VRTX Position: Q2 2026 in Review

GF Fund Management reduced its Vertex Pharmaceuticals (VRTX) stake by 3% in Q2 2026, selling an estimated $848K and leaving 62,678 shares worth $31.1M. The position accounts for 0.37% of the portfolio, ranked #50.

GF Fund Management first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

GF Fund Management held 62,678 shares of Vertex Pharmaceuticals worth $31.1M as of Q2 2026.
GF Fund Management sold 1,913 Vertex Pharmaceuticals shares in Q2 2026, an estimated $848K.
Vertex Pharmaceuticals made up 0.37% of GF Fund Management's portfolio in Q2 2026, its #50 holding.
GF Fund Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.